Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Uploaded by THTX

<< Previous

Bullboard Posts

Next >>

Comment by SPCEO1on Feb 11, 2022 1:06pm

124 Views

Post# 34420849

RE:RE:RE:RE:Uploaded by THTX

Just guessing but I am pretty sure those are the UQAM labs as it looked the same as labs in the TV program where Dr. Beliveau spoke to the reporter about how it was one of the first times his research was lining up with actual results (we just cannot be sure if he was referring to pre-clinical results or phase 1a results but he shouldhave had some knowledge fo thephase 1a progress by t he time the TV program was recorded).

Wino115 wrote: Anyone know, are those THTX offices or UQAM labs THTX farms in to? Just curious.

palinc2000 wrote: The video has english subtitles

Dcutter101 wrote: Is there something in English, or does someone have this quote in context?